Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03430427 · ClinicalTrials.gov registry record
Brain Networks and Mobility Function: B-NET
A clinical trial of White Matter Disease and Central Nervous System, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 192
- Enrollment target
- 1
- Study location
NCT03430427 is a study of White Matter Disease and Central Nervous System that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 192 participants, below the 4,050-participant average among 3 other White Matter Disease trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03430427, a study of White Matter Disease and Central Nervous System, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 192 participants
- Enrollment target
- 1
- Study location
Study Summary
Rapidly accumulating evidence indicates that the central nervous system (CNS) plays a pivotal role in mobility function with age-associated CNS changes strongly contributing to declining mobility. Studies linking the brain to mobility have used anatomical measures like brain volume and white matter integrity, and suggest that damage to the connecting fibers of the brain (white matter) is related to mobility impairment. Unfortunately, age-related structural white matter damage appears irreversible and only indirectly indicates the functional connectivity between brain regions. It is believed that functional brain network analyses have the potential to identify individuals that may benefit from interventions prior to the development of irreversible white matter lesions. The current project will assess both physical and cognitive function and integrate these variables with measures of brain network connectivity.
Conditions Studied
Study Locations (1)
North Carolina
- Wake Forest Baptist Medical Center - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 2018-07-20 |
| Est. Completion | 2023-07-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03430427
The ClinicalTrials.gov registry entry for NCT03430427 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 192 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,050-participant average among 3 other White Matter Disease trials with a reported enrollment target (95% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with White Matter Disease appearing as the primary indexed condition, and to 0 interventions.
NCT03430427 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT03430427 about?
NCT03430427 is a clinical study titled "Brain Networks and Mobility Function: B-NET". Rapidly accumulating evidence indicates that the central nervous system (CNS) plays a pivotal role in mobility function with age-associated CNS changes strongly contributing to declining mobility. Studies linking the brain to mobility have used anatomical measures like brain volume and white matter ...
What is the current status of trial NCT03430427?
This trial is currently completed. The enrollment target is 192 participants. The study started on 2018-07-20. Estimated completion is 2023-07-12.
What conditions does trial NCT03430427 study?
This clinical trial studies the following conditions: White Matter Disease, Central Nervous System.
Who is sponsoring clinical trial NCT03430427?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03430427 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for White Matter Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.